PGC-1beta in the Regulation of Hepatic Lipid Metabolism
PGC-1beta 对肝脏脂质代谢的调节
基本信息
- 批准号:8010020
- 负责人:
- 金额:$ 3.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:ApolipoproteinsBiochemicalBiologicalBlood GlucoseCholesterolChromatin Remodeling FactorDataDiseaseDyslipidemiasEpidemicFatty AcidsFatty acid glycerol estersGap JunctionsGene ExpressionGoalsHepaticHomeostasisHormonalHyperglycemiaHyperlipidemiaHypertriglyceridemiaInsulin ResistanceLinkLipidsLipoproteinsLiverMaintenanceMediatingMetabolicMetabolic DiseasesMetabolic syndromeMetabolismMolecularMusNon-Insulin-Dependent Diabetes MellitusNuclear Hormone ReceptorsNutritionalObesityPathogenesisPathway interactionsPlasmaPlayPositioning AttributeRNA InterferenceRecruitment ActivityRegulationResearch PersonnelRoleSignal PathwaySignal TransductionSyndromeTestingTranscription CoactivatorTransgenic MiceTransgenic OrganismsTriglyceridesadenoviral-mediatedbaseblood glucose regulationcardiovascular disorder riskchromatin remodelinggenome-wideinsightinsulin sensitivitylipid biosynthesislipid metabolismlipid transportlipoprotein triglyceridenovelprogramssaturated fattranscription factor
项目摘要
DESCRIPTION (provided by applicant): Metabolic syndrome is emerging as a global epidemic. The profound metabolic dysregulation in this syndrome is typically manifested by clustering of several disorders, including obesity, type 2 diabetes, and dyslipidemia, and is associated with an increased risk for cardiovascular disease. Hepatic lipogenesis and lipoprotein metabolism are important in maintaining lipid homeostasis. There is increasing evidence that hepatic lipid metabolism plays an important role in the pathogenesis of key aspects of metabolic syndrome, including hyperlipidemia, hyperglycemia, and insulin resistance. We have recently demonstrated that transcriptional coactivator PGC-1? coordinately regulates lipogenesis, lipid trafficking, and lipoprotein metabolism in the liver. These data suggest that PGC-1? is a central component of the regulatory network in maintaining lipid homeostasis. The major goals of this proposal are to test the hypothesis that PGC-1? is involved in the pathogenesis of metabolic syndrome and serves as a molecular link between lipid metabolism and insulin resistance. In addition, molecular components of the PGC-1? pathway will be dissected and analyzed. Aim 1 is to determine evaluate the role of PGC-1? in the pathogenesis of metabolic dysregulation and in linking lipid metabolism to insulin resistance. Aim 2 is to define transcriptional components underlying PGC-1? regulation of triglyceride and lipoprotein metabolism. Aim 3 is to investigate the role of chromatin remodeling in lipid metabolism. Completion of this proposal will define the molecular details of a major regulatory network in the maintenance of lipid homeostasis.
描述(由申请人提供):代谢综合征正在成为全球流行病。该综合征的深刻代谢失调通常由多种疾病的聚类(包括肥胖,2型糖尿病和血脂异常)表现出来,并且与心血管疾病的风险增加有关。肝脂肪生成和脂蛋白代谢对于维持脂质稳态很重要。越来越多的证据表明,肝脂质代谢在代谢综合征的关键方面的发病机理中起着重要作用,包括高脂血症,高血糖和胰岛素抵抗。我们最近证明了转录共激活因子PGC-1吗?协调调节肝脏中的脂肪生成,脂质运输和脂蛋白代谢。这些数据表明PGC-1?是维持脂质稳态的监管网络的核心组成部分。该提案的主要目标是检验PGC-1的假设?参与了代谢综合征的发病机理,并作为脂质代谢和胰岛素抵抗之间的分子联系。另外,PGC-1的分子成分?途径将被解剖和分析。 AIM 1是确定评估PGC-1的作用?在代谢失调的发病机理以及将脂质代谢与胰岛素抵抗联系起来的过程中。 AIM 2是定义PGC-1基础的转录组件?调节甘油三酸酯和脂蛋白代谢。目标3是研究染色质重塑在脂质代谢中的作用。该提案的完成将定义脂质稳态维持主要调节网络的分子细节。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiandie D Lin其他文献
Jiandie D Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiandie D Lin', 18)}}的其他基金
Hepatic TrkB-T1 signaling in NASH pathogenesis and resolution
NASH 发病机制和解决方案中的肝脏 TrkB-T1 信号传导
- 批准号:
10675970 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
NASH-associated macrophages: regulation and role in disease pathogenesis
NASH 相关巨噬细胞:疾病发病机制中的调节和作用
- 批准号:
10675885 - 财政年份:2023
- 资助金额:
$ 3.2万 - 项目类别:
Hepatokine Regulation of Thermogenesis and Metabolic Physiology
肝因子对生热和代谢生理学的调节
- 批准号:
10376212 - 财政年份:2019
- 资助金额:
$ 3.2万 - 项目类别:
Hepatokine Regulation of Thermogenesis and Metabolic Physiology
肝因子对生热和代谢生理学的调节
- 批准号:
9760079 - 财政年份:2019
- 资助金额:
$ 3.2万 - 项目类别:
Hepatokine Regulation of Thermogenesis and Metabolic Physiology
肝因子对生热和代谢生理学的调节
- 批准号:
9894795 - 财政年份:2019
- 资助金额:
$ 3.2万 - 项目类别:
Hepatokine Regulation of Thermogenesis and Metabolic Physiology
肝因子对生热和代谢生理学的调节
- 批准号:
10132313 - 财政年份:2019
- 资助金额:
$ 3.2万 - 项目类别:
Endocrine regulation of metabolic health during aging
衰老过程中代谢健康的内分泌调节
- 批准号:
9277806 - 财政年份:2017
- 资助金额:
$ 3.2万 - 项目类别:
Dissecting the NRG4 hormonal checkpoint in metabolic liver disease
剖析代谢性肝病中的 NRG4 激素检查点
- 批准号:
10206110 - 财政年份:2015
- 资助金额:
$ 3.2万 - 项目类别:
相似国自然基金
藻类微生物燃料电池CO2藻菌协同生化转化及阴极原位耦合光催化捕获
- 批准号:52306222
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SPION与BMP-2磁生化信号耦合靶向新生骨精准改善成骨微环境的研究
- 批准号:82370930
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
耦合生物物理与生化地球化学过程的土地覆被变化多尺度气候效应研究
- 批准号:42371102
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
入核效应蛋白SidW的生化及生物学功能
- 批准号:32370196
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
力信号与生化信号协同调制免疫细胞两个关键界面过程的生物物理研究
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Hyperphosphorylated tau and the molecular mechanisms of tauopathy
过度磷酸化的 tau 蛋白和 tau 蛋白病的分子机制
- 批准号:
10447253 - 财政年份:2022
- 资助金额:
$ 3.2万 - 项目类别:
Post-translational Control of Triglyceride and Cholesterol Metabolism by ANGPTL3 & ANGPTL8 in ApoBCL Clearance
ANGPTL3 对甘油三酯和胆固醇代谢的翻译后控制
- 批准号:
10543874 - 财政年份:2022
- 资助金额:
$ 3.2万 - 项目类别:
Proteomic and functional analysis of missense variants of APOE associated with Alzheimer disease risk
与阿尔茨海默病风险相关的 APOE 错义变异的蛋白质组学和功能分析
- 批准号:
10536747 - 财政年份:2022
- 资助金额:
$ 3.2万 - 项目类别:
Targeting the longevity regulator PAPP-A with small molecule inhibitors
使用小分子抑制剂靶向寿命调节剂 PAPP-A
- 批准号:
10464342 - 财政年份:2022
- 资助金额:
$ 3.2万 - 项目类别:
A spatially resolved joint cortical metabolome and proteome in aging and menopause for the rhesus macaque
恒河猴衰老和更年期的空间分辨联合皮质代谢组和蛋白质组
- 批准号:
10701771 - 财政年份:2022
- 资助金额:
$ 3.2万 - 项目类别: